Preparation of enantiopure 4-oxygenated pipecolic acid derivatives

Tetrahedron

Volumn 53, Issue 46, 1997, Pages 15671-15680

  Bousquet, Yves ^a   Anderson, Paul C ^a   Bogri, Tibor ^a   Duceppe, Jean Simon ^a   Grenier, Louis ^a,b   Guse, Ingrid ^a  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^b ProScript Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIPECOLIC ACID DERIVATIVE;

ARTICLE; DECARBOXYLATION; DRUG SYNTHESIS; ENANTIOMER; HYDROGENATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0030735857     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(97)10059-X     Document Type: Article

References (37)

1. Kessler, H.; Kühn, M. and Löschner, T. Liebigs Ann. Chem. 1986, 1-20.
2. Reed, J. W.; Purvis, M. B.; Kingston, D. G. I.; Biot, A. and Gosselé, F. J. Org. Chem. 1989, 54, 1161.
3. (a) Schenk, V. W. and Schütte, H. R. Flora 1963, 153, 426.
4. (b) Romeo, J. T.; Swain, L. A. and Bleecker, A. B. Phytochemistry 1983, 22, 1615.
5. Romeo, J. T. and Morton, T. C. In Advances in Legume Systematics 5 : The Nitrogen Factor; Sprent, J. C. and McKey, D. Eds; Royal Botanical Gardens, Kew, 1994, pp. 89-99.
6. Vanderhaeghe, H.; Janssen, G. and Compernolle, F. Tetrahedron Lett. 1971, 28, 268
7. (a) Essawi, M. Y. and Portoghese, P. S. J. Heterocycl. Chem. 1983, 20, 477.
8. (b) Hartmann, P. and Obrecht, J. -P. Synth. Commun. 1988, 18, 553.
9. Ornstein, P. L.; Schoepp, D. D.; Arnold, M. B.; Leander, J. D.; Lodge, D.; Paschal, J. W. and Elzey, T. J. Med. Chem. 1991, 34, 90.
10. Hays, S. J.; Malone, T. C. and Johnson G. J. Org. Chem. 1991, 56, 4084.
11. (e) Herdeis, C.; Engel, W. Arch. Pharm. (Weinheim) 1992, 325, 419.
12. (f) Mühlemann, C.; Hartmann, P.; Obrecht, J. -P. Org. Syn. 1992, 71, 200.
13. (a)Jollès, G.; Poiget, G.; Robert, J.; Terlain, B. and Thomas, J.-P. Bull. Soc. Chim. Fr. 1965, 2252.
14. (b) Fujita, Y.; Kollonitsch, J. and Witkop, B.B. J. Am. Chem. Soc. 1965, 87, 2030.
15. Pellicciari, R.; Natalini, B.; Luneia, R.; Marinozzi, M.; Roberti, M.; Rosato, G. C.; Sadeghpour, B. M.; Snyder, J. P.; Monahan, J. B. and Moroni, F. Med. Chem. Res. 1992, 2, 491
16. Jackson, R. F. W.; Graham, L. J. and Rettie, A. B. Tetrahedron Lett. 1994, 35, 4417.
17. (e) Golubev, A.; Sewald, N. and Burger, K. Tetrahedron Lett. 1995, 36, 2037.
18. (f) Machetti, F.; Cordero, F. M.; De Sarlo, F.; Guarna, A. and Brandi, A. Tetrahedron Lett. 1996, 37, 4205.
19. (a) Anderson, P. C.; Soucy, F.; Yoakim, C.; Lavallée, P. and Beaulieu, P. L. U.S. patent 5 545 640, 1996.
20. (b) Lamarre, D.; Croteau, G.; Bourgon, L.; Thibeault, D.; Wardrop, E.; Clouette, C.; Vaillancourt, M.; Cohen, E.; Pargellis, C.; Yoakim, C. and Anderson, P. C. Antimicrobial Agents and Chemotherapy, 1997, 41, 965.
21. (a) Beaulieu, P. L.; Wernic, D.; Duceppe, J.-S.; and Guindon, Y. Tetrahedron Lett. 1995, 36, 3317.
22. (b) Beaulieu, P. L. and Wernic, D. J. Org. Chem. 1996, 61, 3635.
23. (a) Gillard, J.; Abraham, A.; Anderson, P. C.; Beaulieu, P. L.; Bogri, T.; Bousquet, Y.; Grenier, L.; Guse, I. and Lavallée, P. J. Org. Chem. 1996, 61, 2226.
24. (b) Beaulieu, P. L.; Lavallée, P.; Abraham, A.; Anderson, P. C.; Boucher, C.; Bousquet, Y.; Duceppe, J.-S.; Gillard, J.; Gorys, V.; Grand-Maître, C.; Grenier, L.; Guse, I.; Plamondon, L.; Soucy, F.; Valois, S.; Wernic, D. and Yoakim, C. J. Org. Chem. 1997, 62, 3440.
25. Castro, B.; Dormoy, J.R.; Evin, G. and Selve, C. Tetrahedron Lett. 1975, 14, 1219.
26. Brooks, D.W.; Lu, L. D. -L and Masamune, S. Angew. Chem. Intl. Ed. Engl. 1979, 18, 72.
27. Valasinas, A.; Levy, E. S. and Frydman, B. J. Org. Chem. 1974, 39 2872.
28. For a review of the chemistry of formamide acetals see : Abdulla, R. F. and Brinkmeyer, R. S. Tetrahedron 1979, 35, 167 5.
29. Plante, R. Personal communication.
30. Ultimately the absolute stereochemistry was proven when an X-ray structure of palinavir dihydrochloride was obtained with material which was identical in all aspects with the one described here, see ref. 9b.
31. For a related approach see : Christie, B. D. and Rapoport, H. J. Org. Chem. 1985, 50, 1239.
32. ß-Methyl L-aspartate hydrochloride was purchased from Omega Chemicals, Québec city or was readily prepared from thionyl chloride and L-aspartic acid in methanol. See: Khosla, M. C.; Smeby, R. R. and Bumpus, F. M. Ind. J. Chem. 1967, 5 (6), 279 and references cited therein.
33. Three equivalents of sodium methoxide were required for optimal results in this transformation. Use of fewer equivalents of sodium methoxide or use of other bases i.e. : NaH, KH, KO-t-Bu, LiHMDS, NaHMDS, or KHMDS all resulted in lower yields.
34. Knorr, R.; Trzeciak, A.; Bannwarth, W. and Gillessen, D. Tetrahedron Lett. 1989, 30, 1927.
35. (R)-(-)-1-indanol and (S)-(+)-1-indanol were purchased from Aldrich Chemical Co. The (R)-(-) enantiomer was found to have an ee of 99.8% and the (S)-(+) enantiomer was found to have an ee of 99.7%. These ee's were obtained by HPLC analysis using a Daicel chiral pak AS 4.6 × 250 mm column, eluent: 10% EtOH/hexane isocratic at 0.5 mL/min., PDA detector at 205 nm.
36. Neises, B. and Steglich, W. Angew. Chem. Int. Ed. Engl. 1978, 17, 522.
37. R for the (R)-indanyl ester : 13.5 min (detection limit <0.5%).